Description

Felypressin (PLV-2) is a non-catecholamine vasoconstrictor and a vasopressin 1 agonist. Felypressin is widely used in dental procedures[1][2].–80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)–COVID-19-immunoregulation–C46H65N13O11S2—J Pharm Biomed Anal. 2022: 115156.|University of Saskatchewan. 2020 Jun 22.|J Pharm Biomed Anal. 11 December 2021, 114518.-[1]Bronzo AL et al. Felypressin increases blood pressure during dental procedures in hypertensive patients. Arq Bras Cardiol. 2012 Aug;99(2):724-31.|[2]Cecanho R et al. Cardiovascular effects of felypressin. Anesth Prog. 2006 Winter;53(4):119-25.–56-59-7–1040.22–99.64–O=C([C@H](CSSC[C@@H](C(N[C@H](C1=O)CC2=CC=CC=C2)=O)N)NC([C@@H](NC([C@@H](NC([C@](N1)([H])CC3=CC=CC=C3)=O)CCC(N)=O)=O)CC(N)=O)=O)N(CCC4)[C@@H]4C(N[C@@H](CCCCN)C(NCC(N)=O)=O)=O–Cardiovascular Disease–DMSO : ≥ 10.4 mg/mL–Vasopressin Receptor—-GPCR/G Protein–Peptides